REN and atrial fibrillation: The renin–angiotensin–aldosterone system (RAAS) has emerged as a pivotal mediator in this interplay, with its activation contributing to both atrial remodelling and inflammation, further perpetuating AF and mitigating the impact of anti-AF treatments [13].